Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07729241) titled 'COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival' on July 21.

Study Type: Observational

Primary Sponsor: Groupe Hospitalier Pitie-Salpetriere

Condition: Cancer Immune Checkpoint Inhibitors COVID-19 Vaccination Survival

Recruitment Status: Not recruiting

Date of First Enrollment: December 28, 2020

Target Sample Size: 95015

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07729241

Published by HT Digital Content Services with permission from Health Daily Digest....